Sequel spiral tampons, the winner of this year’s Hygienix Innovation Award, will soon be available at select locations in New York and California. This announcement comes just six months after the tampon startup, founded by two Stanford-educated engineers and former high performance athletes, announced the tampon had received FDA clearance for marketing in the U.S.
 
Sequel’s mission is to raise the standard of women’s products with better design and superior technology. As the company’s first novel product, the Sequel Spiral Tampon features a proprietary spiral design that is engineered to be more fluid mechanically efficient, meaning it is designed to absorb more evenly and not leak before it’s full. The company has been granted 11 patents in the U.S. and globally with seven additional patents pending internationally. They have developed a proprietary manufacturing method that enabled them to scale up quickly and transition from proof-of-concept manual manufacturing to automatic manufacturing.

As a part of the FDA clearance process, Sequel performed extensive testing and documentation of the safety and efficacy of the product, which validates the company’s confidence in the design of the Sequel Spiral Tampon.

In early 2023, Sequel announced a partnership with Albaad, the world’s largest manufacturer of femcare products and wet wipes, to manufacturer the spiral tampon in Israel.
 
The Sequel team is strategically choosing to start slow in order to create a loyal fan base. Sequel will continue to roll out in additional states throughout the year based on consumer demand.  Sequel will initially be available at barre workout studio Physique 57 in New York and will roll out at additional New York and California locations.